BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25584678)

  • 1. An oncogenic enhancer enemy (N-Me) in T-ALL.
    Herranz D; Ferrando AA
    Cell Cycle; 2015; 14(2):167-8. PubMed ID: 25584678
    [No Abstract]   [Full Text] [Related]  

  • 2. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
    Herranz D; Ambesi-Impiombato A; Palomero T; Schnell SA; Belver L; Wendorff AA; Xu L; Castillo-Martin M; Llobet-Navás D; Cordon-Cardo C; Clappier E; Soulier J; Ferrando AA
    Nat Med; 2014 Oct; 20(10):1130-7. PubMed ID: 25194570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymocyte transformation enhanced.
    Pouliot GP; Gutierrez A
    Nat Med; 2014 Oct; 20(10):1096-7. PubMed ID: 25295936
    [No Abstract]   [Full Text] [Related]  

  • 4. T-ALL pathogenesis requires a NOTCH1-driven MYC enhancer.
    Cancer Discov; 2014 Nov; 4(11):OF17. PubMed ID: 25367958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
    Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.
    Antoszewski M; Fournier N; Ruiz Buendía GA; Lourenco J; Liu Y; Sugrue T; Dubey C; Nkosi M; Pritchard CEJ; Huijbers IJ; Segat GC; Alonso-Moreno S; Serracanta E; Belver L; Ferrando AA; Ciriello G; Weng AP; Koch U; Radtke F
    Blood; 2022 Apr; 139(16):2483-2498. PubMed ID: 35020836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch.
    Bayer M; Grosschedl R
    Mol Cell; 2022 Mar; 82(5):884-886. PubMed ID: 35245453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of EZH2, NOTCH1, IL7R, and PHF6 Mutations in Adult T-cell Acute Lymphoblastic Leukemia.
    Zhou X; Gu Y; Han Q; Soliman M; Song C; Ge Z
    Turk J Haematol; 2017 Dec; 34(4):366-368. PubMed ID: 28747286
    [No Abstract]   [Full Text] [Related]  

  • 9. A Tumor Suppressor Enhancer of
    Tottone L; Lancho O; Loh JW; Singh A; Kimura S; Roels J; Kuchmiy A; Strubbe S; Lawlor MA; da Silva-Diz V; Luo S; Gachet S; García-Prieto CA; Hagelaar R; Esteller M; Meijerink JPP; Soulier J; Taghon T; Van Vlierberghe P; Mullighan CG; Khiabanian H; Rocha PP; Herranz D
    Blood Cancer Discov; 2021 Jan; 2(1):92-109. PubMed ID: 33458694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of identical NOTCH1 mutation in non-twinned sisters with T-cell acute lymphoblastic leukemia.
    Mansur MB; Ford AM; van Delft FW; Gonzalez D; Emerenciano M; Maia RC; Greaves M; Pombo-de-Oliveira MS
    Leukemia; 2011 Aug; 25(8):1368-70. PubMed ID: 21556011
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphatase PRL2 promotes oncogenic NOTCH1-Induced T-cell leukemia.
    Kobayashi M; Bai Y; Chen S; Gao R; Yao C; Cai W; Cardoso AA; Croop J; Zhang ZY; Liu Y
    Leukemia; 2017 Mar; 31(3):751-754. PubMed ID: 27872499
    [No Abstract]   [Full Text] [Related]  

  • 12. Complexity of NOTCH1 juxtamembrane insertion mutations in T-cell acute lymphoblastic leukemia.
    Colomer-Lahiguera S; Strehl S
    Leuk Lymphoma; 2016 May; 57(5):1219-22. PubMed ID: 26292904
    [No Abstract]   [Full Text] [Related]  

  • 13. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
    Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
    Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34).
    Yamamoto K; Nakamachi Y; Yakushijin K; Miyata Y; Okamura A; Kawano S; Matsuoka H; Minami H
    Eur J Haematol; 2013 Jan; 90(1):68-75. PubMed ID: 23033986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients.
    Abualhaj NZ; Dardas Z; Azab B; Ali D; Sughayer MA; Aladily TN; Ahram M
    Ann Diagn Pathol; 2019 Apr; 39():53-58. PubMed ID: 30718223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements.
    Mansur MB; Emerenciano M; Splendore A; Brewer L; Hassan R; Pombo-de-Oliveira MS;
    Leuk Res; 2010 Apr; 34(4):483-6. PubMed ID: 19631984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.
    Valliyammai N; Nancy NK; Sagar TG; Rajkumar T
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e1-e8. PubMed ID: 29200162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
    Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
    J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.
    Waibel M; Vervoort SJ; Kong IY; Heinzel S; Ramsbottom KM; Martin BP; Hawkins ED; Johnstone RW
    Leukemia; 2018 Jan; 32(1):237-241. PubMed ID: 28914259
    [No Abstract]   [Full Text] [Related]  

  • 20. A second NOTCH1 chromosome rearrangement: t(9;14)(q34.3;q11.2) in T-cell neoplasia.
    Suzuki S; Nagel S; Schneider B; Chen S; Kaufmann M; Uozumi K; Arima N; Drexler HG; MacLeod RA
    Leukemia; 2009 May; 23(5):1003-6. PubMed ID: 19151773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.